o2h discovery
Changodar, India o2hdiscovery.co From their website, Nov 2026
Work here? Claim this listing
About
o2h discovery is a contract research organisation with integrated drug discovery capabilities for biotech and pharmaceutical clients. It operates from research centres in Ahmedabad, India and Cambridge, UK, and also lists a USA location in Cambridge, Massachusetts.
Services
Target Identification and Validation
Supports target identification and validation within an integrated drug discovery platform.
Hit Identification
Provides hit identification services as part of the drug discovery workflow.
Hit to Lead
Advances identified hits into lead series.
Lead Optimization
Supports lead optimization programs for drug discovery projects.
Targeted protein degradation
Offers targeted protein degradation services.
Fragment-based Drug Discovery
Provides fragment-based drug discovery services.
Knowledge-based drug design and SAR
Uses knowledge-based drug design and SAR to support discovery programs.
Early assessment of in vitro ADMET and PK
Provides early in vitro ADMET and pharmacokinetic assessment.
22 more services
- Medicinal Chemistry Services
- Synthetic Chemistry
- Peptide synthesis service
- PROTAC Services
- Lipid Nanoparticles (LNPs)
- Analytical chemistry
- ADCs – linker/payloads
- Biology target engagement and validation
- PROTAC NanoBRET/NanoBiT
- NaLTSA
- Genetic engineering
- siRNA/shRNA
- Undruggable targets and genetic benchmarking
- Biophysical
- Biochemical
- Cellular
- Gene expression
- Drug-Drug interactions and synthetic lethality
- Biomarker assessment
- Site-directed mutagenesis & binding studies
- Drug Screening
- DMPK in-vitro ADME
- Turnaround
- 2 weeks
- Get peptides delivered in 2 weeks
Capabilities
- Assays and studies
- Peptides
- Custom synthesis
- Small molecules
- ADME
- Peptide synthesis
- LNP
23 more
- High-content imaging
- PK/PD
- ADCs
- SPR
- Surface Plasmon Resonance
- Fluorescence Polarization (FP)
- Thermal Shift Assay
- Enzymes
- Fluorescence and Luminescence-based studies
- ELISA/AlphaLISA
- Proliferation, viability and cytotoxicity
- 3D cultures
- Intracellular signaling
- Mechanism of Action (MoA)
- Cell cycle analysis
- Cell population analysis
- Gene expression
- qRT-PCR
- Fluorescence Polarization
- ELISA
- AlphaLISA
- Proliferation
- Viability
- Scale and capacity
- Gram to Kg
- Kilo-lab
- Non-GMP
- GMP [partnership]
- Small quantities of a few milligrams
- Gram scale
3 more
- Up to 50-mer linear peptides
- Scale-up up to 200L
- 500 FTEs
- Therapeutic areas
- Immuno-Oncology
- Psychedelics
Instruments and platforms
- Surface Plasmon Resonance
- NanoBRET
- NanoBiT
- High-content imaging
Modalities and species
- Modalities
- Small molecule
- Antibody
- ADC
- Peptide
- Oligonucleotide
- LNP / formulation
Industries served
- Biotech
- Life sciences
Details
- Type
- CRO
- Founded
- 2004
- Office
- covering 42 FTEs for a UK-based collaborator. He has worked with client
- Sites
- Ahmedabad, India
- Cambridge, UK
- Cambridge, MA, United States
- Serves
- Europe, USA, Japan, global